Elevance Health, Inc. — Earnings Quality Grade D
ELV · Healthcare
Significant concerns
Screening Summary
Management Signals
Source: SEC EDGAR 8-K Item 5.02, with exhibit links when available
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 18 days, change +2 days YoY
AR growth 25.7% exceeds revenue growth 12.6%
Revenue grew 12.6% but CFFO declined -26.1%
Expense Quality
No material inventory
CapEx growth -11.1% vs revenue 12.6%. Normal
Insufficient data
Insufficient data
Cash Flow Quality
CFFO/NI = 0.76. Below 1.0
FCF $3.2B, FCF/NI = 0.56
Accruals ratio = 1.1%. Low accruals
Cash $35.4B covers debt $32.0B
Balance Sheet Health
Goodwill+Intangibles $39.5B = 90% of equity. Over 50%
Insufficient data
Insufficient data
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change -2% YoY. Normal
Manipulation Score
Insufficient data
Portfolio monitoring
Monitor ELV continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25